Cooley advised Instacart, and Latham & Watkins advised the underwriters. Maplebear Inc. d/b/a Instacart announced the pricing of its initial public offering of 22,000,000 shares of its...
Instacart’s $660 Million Initial Public Offering
Perplexity.AI’s Acquisition of Spellwise
Latham & Watkins advised Perplexity on the deal. Perplexity.AI announced it acquired Spellwise. The acquisition will support mobile product development, as well as better user experience with...
Essential Properties Realty Trust’s $240 Million Common Stock Public Offering
Sidley Austin and Venable advised Essential Properties, while Latham and Watkins advised the underwriters. Essential Properties Realty Trust, Inc. (NYSE: EPRT) announced the pricing of an...
Advantage Capital and Sumitomo’s Formation of Perennial Renewables
Latham & Watkins represented Advantage Capital in the deal. Sumitomo Corporation, through Sumitomo Corporation of Americas and together with Advantage Capital established Perennial Renewables LLC, a limited liability...
Boston Scientific’s $850 Million Acquisition of Relievant MedSystems
Faegre Drinker advised Boston Scientific, and Latham & Watkins advised Relievant MedSystems on the deal. Boston Scientific Corporation (NYSE: BSX) announced it has entered into a...
Sierra Pacific Power Company’s $400 Million Notes Offering
ArentFox Schiff advised Sierra Pacific, and Latham & Watkins advised the initial purchasers. Sierra Pacific Power Company priced $400 million aggregate principal amount of its 5.900%...
Vital Energy’s Accretive Transactions
Vinson & Elkins advised Vital Energy, Inc. and Maple Energy Holdings, Kirkland & Ellis advised Tall City Property Holdings III LLC and Jackson Walker advised Henry...
Neumora Therapeutics’ $250.1 Million Initial Public Offering
Latham & Watkins advised Neumora, and Cooley advised the underwriters. Neumora Therapeutics, Inc. announced the pricing of its initial public offering of 14,710,000 shares of its common...
Otsuka’s Collaboration with ShapeTX
Latham & Watkins advised ShapeTX on the deal. Otsuka Pharmaceutical Co., Ltd. and ShapeTX announced a multi-target collaboration to develop intravitreally-delivered adeno-associated viruses (AAVs) for ocular...
Crinetics Pharmaceuticals’ $350 Million Public Offering of Common Stock
Latham & Watkins advised Crinetics, and Cooley advised the underwriters on the offering. Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) announced the pricing of an upsized underwritten public...
Diamond Offshore Drilling’s $550 Million Notes Private Placement
Vinson & Elkins represented Diamond Offshore Drilling, and Latham & Watkins represented the initial purchasers in the transaction. Diamond Foreign Asset Company and Diamond Finance, LLC,...
Vista Credit Partners’ $150 Million Equity Investment in VideoAmp
Akin advised Vista Credit Partners, and Latham & Watkins advised VideoAmp. VideoAmp announced $150 million in Series G funding led by Vista Credit Partners. The funding...